Apatinib Combined With Albumin-Bound Paclitaxel for Treatment of Advanced Triple Negative Breast Cancer
Status: UNKNOWN
Study type: INTERVENTIONAL
Conditions: Advanced Triple Negative Breast Cancer
Interventions: DRUG: Apatinib Mesylate|DRUG: Albumin-Bound Paclitaxel
Sponsor: Fujian Cancer Hospital